Impact of Hepatitis B-Active Combination Antiretroviral Therapy on Hepatitis B Susceptibility in Newly Diagnosed HIV Patients

被引：2
|
作者：
Calisti, Giorgio [1 ]
Capocci, Santino J. [2 ]
Ware, Alexander [1 ]
Dudill, Rebecca [1 ]
Smith, Colette [3 ]
Johnson, Margaret A. [2 ]
Lipman, Marc C. I. [2 ,4 ]
Webster, Daniel P. [1 ]
机构：
[1] Royal Free London NHS Fdn Trust, Dept Virol, London NW3 2QG, England
[2] Royal Free London NHS Fdn Trust, Dept Thorac & HIV Med, London NW3 2QG, England
[3] UCL, Res Dept Infect & Populat Hlth, London, England
[4] UCL, Dept Resp Med, London, England
来源：
CLINICAL INFECTIOUS DISEASES | 2014年 / 58卷 / 01期
关键词：
INFECTED ADULTS; GUIDELINES; SOCIETY;
D O I：
10.1093/cid/cit607
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：137 / +
页数：3
相关论文
共 50 条
  • [1] Lamivudine-resistant hepatitis B virus in newly diagnosed HIV patients with chronic hepatitis B in Spain
    Trevino, A.
    Soriano, V.
    Rodriguez, C.
    Madejon, A.
    Barros, C.
    Parra, P.
    Tuma, P.
    del Romero, J.
    de Mendoza, C.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (04) : A65 - A65
  • [2] Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy
    Filippini, Pietro
    Coppola, Nicola
    Pisapia, Raffaella
    Scolastico, Carlo
    Marrocco, Cecilia
    Zaccariello, Antonella
    Nacca, Cesare
    Sagnelli, Caterina
    De Stefano, Giulio
    Ferraro, Teresa
    De Stefano, Carlo
    Sagnelli, Evangelista
    [J]. AIDS, 2006, 20 (09) : 1253 - 1260
  • [3] Antiretroviral therapy for patients with HIV-hepatitis B virus coinfection
    McGovern, Barbara
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (07) : 1012 - 1013
  • [4] Antiretroviral therapy and HIV/hepatitis B virus coinfection
    Benhamou, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 : S98 - S103
  • [5] Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center
    Yang, Rongrong
    Gui, Xien
    Xiong, Yong
    Gao, Shi-cheng
    Yan, Yajun
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 28 : 29 - 34
  • [6] Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy
    Hawkins, Claudia
    Kang, Minhee
    Bhattacharya, Debika
    Cloherty, Gavin
    Kuhns, Mary
    Matining, Roy
    Thio, Chloe
    Samaneka, Wadzanai
    Chinula, Lameck
    Mulinda, Nyirenda
    Badal-Faesen, Sharlaa
    Sugandhavesa, Patcharaphan
    Lama, Javier
    Gaseitsiwe, Simani
    Holzmayer, Vera
    Anderson, Mark
    Murphy, Robert
    Peters, Marion
    [J]. AIDS, 2022, 36 (07) : 975 - 984
  • [7] Antiretroviral therapy for hepatitis B virus - HIV - Coinfected patients: Promises and pitfalls
    Levy, Vivian
    Grant, Robert M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) : 904 - 910
  • [8] Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients
    Unger, Joseph M.
    Till, Cathee
    Hwang, Jessica P.
    Arnold, Kathryn B.
    Leblanc, Michael
    Hershman, Dawn L.
    Ramsey, Scott D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (06) : 703 - 711
  • [9] Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
    Sheng, Wang-Huei
    Kao, Jia-Horng
    Chen, Pei-Jer
    Huang, Li-Ming
    Chang, Sui-Yuan
    Sun, Hsin-Yun
    Hung, Chien-Ching
    Chen, Mao-Yuan
    Chang, Shan-Chwen
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (09) : 1221 - 1229
  • [10] Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection
    Fang, CT
    Chen, PJ
    Chen, MY
    Hung, CC
    Chang, SC
    Chang, AL
    Chen, DS
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 (06) : 1028 - 1035
12345